728 related articles for article (PubMed ID: 28212924)
1. IBD immunopathogenesis: A comprehensive review of inflammatory molecules.
Park JH; Peyrin-Biroulet L; Eisenhut M; Shin JI
Autoimmun Rev; 2017 Apr; 16(4):416-426. PubMed ID: 28212924
[TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis of IBD: current state of the art.
de Souza HS; Fiocchi C
Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):13-27. PubMed ID: 26627550
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
Dharmani P; Chadee K
Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
[TBL] [Abstract][Full Text] [Related]
4. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.
Ahluwalia B; Moraes L; Magnusson MK; Öhman L
Scand J Gastroenterol; 2018 Apr; 53(4):379-389. PubMed ID: 29523023
[TBL] [Abstract][Full Text] [Related]
5. The genetics and immunopathogenesis of inflammatory bowel disease.
Cho JH
Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
Gehlert T; Devergne O; Niedobitek G
J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
[TBL] [Abstract][Full Text] [Related]
7. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance].
Stange EF; Schmid M; Fellermann K; Wehkamp J
Praxis (Bern 1994); 2005 Sep; 94(37):1429-32. PubMed ID: 16193905
[TBL] [Abstract][Full Text] [Related]
8. An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
Choy MC; Visvanathan K; De Cruz P
Inflamm Bowel Dis; 2017 Jan; 23(1):2-13. PubMed ID: 27779499
[TBL] [Abstract][Full Text] [Related]
9. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
10. Emerging immunological targets in inflammatory bowel disease.
Monteleone G; Pallone F; MacDonald TT
Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
[TBL] [Abstract][Full Text] [Related]
11. [Immunopathogenesis of inflammatory bowel diseases].
Neurath MF; Schürmann G
Chirurg; 2000 Jan; 71(1):30-40. PubMed ID: 10662999
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
13. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
14. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease.
Torres MI; Le Discorde M; Lorite P; Ríos A; Gassull MA; Gil A; Maldonado J; Dausset J; Carosella ED
Int Immunol; 2004 Apr; 16(4):579-83. PubMed ID: 15039388
[TBL] [Abstract][Full Text] [Related]
15. Chemokines in inflammatory bowel disease.
Papadakis KA
Curr Allergy Asthma Rep; 2004 Jan; 4(1):83-9. PubMed ID: 14680627
[TBL] [Abstract][Full Text] [Related]
16. Immune system alterations in patients with inflammatory bowel disease during remission.
Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
Xu XR; Liu CQ; Feng BS; Liu ZJ
World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798
[TBL] [Abstract][Full Text] [Related]
18. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
19. Advances in understanding the role of cytokines in inflammatory bowel disease.
Bevivino G; Monteleone G
Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):907-915. PubMed ID: 30024302
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]